Presented by the Johns Hopkins University School of Medicine
Supported by an educational grant from Genentech, Inc.
This program is designed for retina specialists and comprehensive
ophthalmologists involved in the diagnosis and treatment of macular
edema. There are no prerequisites for attendees.
At the conclusion of this activity, the participant should
be able to:
- Discuss the pathophysiology of ME
- Identify the latest advances in the understanding of the molecular pathways
leading to ME
- Describe the strategic goals of therapy and the therapeutic options to
- Identify the direct and indirect economic impact of ME
The Johns Hopkins University School of Medicine takes responsibility for the
content, quality, and scientific integrity of this CME activity.
The Johns Hopkins University School of Medicine
is accredited by the Accreditation Council for Continuing Medical Education
to provide continuing medical education for physicians.
Credit Designation Statement
The Johns Hopkins University School of
Medicine designates this educational activity for a maximum of 1.5 AMA PRA
Category 1 Credit(s)™. Physicians should only claim credit commensurate
with the extent of their participation in the activity.
Release Date: January 15, 2008. Expiration Date: January 15, 2010.
Estimated time to complete this activity: 1.5 hours.
Policy on Faculty and Provider Disclosure
It is the policy of the Johns
Hopkins University School of Medicine that the faculty and provider disclose
real or apparent conflicts of interest relating to the topics of this educational
activity, and also disclose discussions of unlabeled/unapproved uses of drugs
or devices during their presentation(s). Johns Hopkins University School of
Medicine OCME has established policies in place that will identify and resolve
all conflicts of interest prior to this educational activity. Detailed disclosure will
be made during the webcast.